Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Obesema Injection, manufactured by Alkem Laboratories Ltd, is a prescription, once-weekly subcutaneous injection containing Semaglutide, designed for long-term weight management, Type 2 diabetes control, and reducing cardiovascular risk in adults with obesity.
| Active Ingredient | Semaglutide |
| Primary Application: | Chronic weight management and Type 2 Diabetes |
| Usage | Once-weekly, subcutaneous injection |
| Class | GLP-1 receptor agonist |